Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort

Eric Lawrence Matteson, Kenneth N. Gold, Daniel A. Bloch, Gene G. Hunder

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

OBJECTIVE: To characterize survivorship among patients with giant cell arteritis in a well-defined, multicenter cohort. PATIENTS AND METHODS: Follow-up was obtained for 205 (95.8%) of the 214 patients enrolled in the 1990 American College of Rheumatology vasculitis classification study. Standardized mortality ratios (SMR) were calculated comparing mortality data from this group of patients with giant cell arteritis versus the general population. RESULTS: There were 49 deaths (33 women and 16 men) among the 205 patients available for follow-up. Survivorship was virtually identical to that of the general population (SMR = 1.034 ± 0.121), and was similar for women (SMR = 1.022 ± 0.149) and men (SMR = 1.078 ± 0.206) (SMR = 1 indicates that expected and observed survival are identical). CONCLUSION: The life expectancy of patients with giant cell arteritis is the same as that of the general population.

Original languageEnglish (US)
Pages (from-to)193-196
Number of pages4
JournalAmerican Journal of Medicine
Volume100
Issue number2
DOIs
StatePublished - Feb 1996

Fingerprint

Giant Cell Arteritis
Survival
Mortality
Survival Rate
Population
Vasculitis
Life Expectancy

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. / Matteson, Eric Lawrence; Gold, Kenneth N.; Bloch, Daniel A.; Hunder, Gene G.

In: American Journal of Medicine, Vol. 100, No. 2, 02.1996, p. 193-196.

Research output: Contribution to journalArticle

@article{059b122db8b541649078bbff0e14a0fb,
title = "Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort",
abstract = "OBJECTIVE: To characterize survivorship among patients with giant cell arteritis in a well-defined, multicenter cohort. PATIENTS AND METHODS: Follow-up was obtained for 205 (95.8{\%}) of the 214 patients enrolled in the 1990 American College of Rheumatology vasculitis classification study. Standardized mortality ratios (SMR) were calculated comparing mortality data from this group of patients with giant cell arteritis versus the general population. RESULTS: There were 49 deaths (33 women and 16 men) among the 205 patients available for follow-up. Survivorship was virtually identical to that of the general population (SMR = 1.034 ± 0.121), and was similar for women (SMR = 1.022 ± 0.149) and men (SMR = 1.078 ± 0.206) (SMR = 1 indicates that expected and observed survival are identical). CONCLUSION: The life expectancy of patients with giant cell arteritis is the same as that of the general population.",
author = "Matteson, {Eric Lawrence} and Gold, {Kenneth N.} and Bloch, {Daniel A.} and Hunder, {Gene G.}",
year = "1996",
month = "2",
doi = "10.1016/S0002-9343(97)89458-2",
language = "English (US)",
volume = "100",
pages = "193--196",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort

AU - Matteson, Eric Lawrence

AU - Gold, Kenneth N.

AU - Bloch, Daniel A.

AU - Hunder, Gene G.

PY - 1996/2

Y1 - 1996/2

N2 - OBJECTIVE: To characterize survivorship among patients with giant cell arteritis in a well-defined, multicenter cohort. PATIENTS AND METHODS: Follow-up was obtained for 205 (95.8%) of the 214 patients enrolled in the 1990 American College of Rheumatology vasculitis classification study. Standardized mortality ratios (SMR) were calculated comparing mortality data from this group of patients with giant cell arteritis versus the general population. RESULTS: There were 49 deaths (33 women and 16 men) among the 205 patients available for follow-up. Survivorship was virtually identical to that of the general population (SMR = 1.034 ± 0.121), and was similar for women (SMR = 1.022 ± 0.149) and men (SMR = 1.078 ± 0.206) (SMR = 1 indicates that expected and observed survival are identical). CONCLUSION: The life expectancy of patients with giant cell arteritis is the same as that of the general population.

AB - OBJECTIVE: To characterize survivorship among patients with giant cell arteritis in a well-defined, multicenter cohort. PATIENTS AND METHODS: Follow-up was obtained for 205 (95.8%) of the 214 patients enrolled in the 1990 American College of Rheumatology vasculitis classification study. Standardized mortality ratios (SMR) were calculated comparing mortality data from this group of patients with giant cell arteritis versus the general population. RESULTS: There were 49 deaths (33 women and 16 men) among the 205 patients available for follow-up. Survivorship was virtually identical to that of the general population (SMR = 1.034 ± 0.121), and was similar for women (SMR = 1.022 ± 0.149) and men (SMR = 1.078 ± 0.206) (SMR = 1 indicates that expected and observed survival are identical). CONCLUSION: The life expectancy of patients with giant cell arteritis is the same as that of the general population.

UR - http://www.scopus.com/inward/record.url?scp=0030025473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030025473&partnerID=8YFLogxK

U2 - 10.1016/S0002-9343(97)89458-2

DO - 10.1016/S0002-9343(97)89458-2

M3 - Article

C2 - 8629654

AN - SCOPUS:0030025473

VL - 100

SP - 193

EP - 196

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 2

ER -